Biotech Stock News (AGN) (PFE) (ICPT)

Allergan (NYSE:ACT) & Pfizer (NYSE:PFE) On April 5, 2016 shares of Allergan had tumbled by 14.77% as investors had become skeptical that the deal with Pfizer would actually go through. The reason for ¬†investors becoming skeptical was because the government had implemented new tax inversion rules. Back in November Pfizer brokered a deal to buy … Read more

Biotech Stock News (OREX) (TKPHF) (VRTX) (PBYI)

Orexigen Therapeutics (NASDAQ:OREX)¬† On May 12, 2015 Shares of Orexigen tanked by 13% after the company reported that the cardiovascular outcome study had to be terminated early. The “LIGHT” study recruited up to 9,000 patients to determine if patients taking Contrave have an increased risk of cardiovascular issues. The mess up occurred because the early … Read more